Almost Half of Pediatric Opioid Prescriptions Considered High-Risk
61.4 percent of the prescriptions written by dentists, surgeons; high-volume prescribers wrote more than half of prescriptions
Addiction/dependence
Secondhand Marijuana Smoke Tied to Respiratory Infections in Children
However, no negative impact seen on emergency department or urgent care visits, otitis media episodes, or asthma exacerbations
Significant Percentage of US Adults With Chronic Pain Use Rx Opioids
Prescription opioid use highest for those aged 45 to 64 years; more likely among women, unemployed adults
Once-Weekly Levomethadone Fast Tracked for Opioid Use Disorder
LYN-014 is an investigational oral, once-weekly, ultra-long-acting, extended-release levomethadone capsule to treat opioid use disorder.
E-Cigarette Use During Pregnancy Tied to Adverse Birth Outcomes
Low birth weight, preterm delivery seen particularly among individuals using e-cigarettes daily
Alcohol Withdrawal: Individualized Care and Pharmacologic Treatment
More than 50% of patients with alcohol use disorder develop alcohol withdrawal symptoms within hours of discontinuing or decreasing alcohol use.
US Drug Overdose Deaths Up ~30% in 2020
Increases seen in overdose deaths from opioids, as well as cocaine and psychostimulants
MPR Weekly Dose Podcast Episode 85
This week Pfizer recalled their smoking cessation therapy Chantix. A treatment for acute bacterial skin and skin structure infections becomes available. Aduhelm, the newly approved Alzheimer Disease treatment, has its label updated. A blood lead level test is recalled, and there’s updates to the cancer drug Keytruda.
FDA to Review Buprenorphine Extended-Release Injection for Opioid Use Disorder
Brixadi (buprenorphine) is an investigational, extended-release weekly and monthly subcutaneous injection for moderate to severe opioid use disorder.
FDA: Dietary Supplements Containing Kratom Seized
The consumption of kratom can lead to serious medical outcomes.
